Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Hereditary Retinopathies : Progress in Development of Genetic and Molecular Therapies, Paperback / softback Book

Hereditary Retinopathies : Progress in Development of Genetic and Molecular Therapies Paperback / softback

Part of the SpringerBriefs in Genetics series

Paperback / softback

Description

The hereditary retinopathy, retinitis pigmentosa (RP), which affects 1 in 3,500 people worldwide, is the most common cause of registered visual handicap among those of the working age in developed countries.

RP is a highly variable disorder where patients may develop symptomatic visual loss in early childhood, while others may remain asymptomatic until mid-adulthood.

Most cases of RP segregate in autosomal dominant, recessive or X-linked recessive modes, with approximately 41 genes being implicated in disease pathology to date (RetNet).

The extensive genetic heterogeneity associated with autosomal dominant RP (adRP) is an undisputed hindrance to the development of genetically based therapeutics.

Information

Other Formats

Save 18%

£54.99

£45.05

Item not Available
 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information

Also in the SpringerBriefs in Genetics series  |  View all